April 2012 Drug Information Update - Pharmacy Benefits ...

37.5 mg/25 mg, 1000 count (NDC 00781-2074-10)
50 mg/25 mg, 100 count (NDC 00781-2715-01)
37.5 mg/25 mg, 500 count (NDC 00781-1123-05)
Triamterene and Hydrochlorothiazide tablets, Mylan
75 mg/50 mg, 100 count (NDC 00378-1355-01)
75 mg/50 mg, 500 count (NDC 00378-1355-05)
Reason for the Shortage
• Watson could not provide a reason for the shortage.
• Sandoz states the shortage is due to a raw material shortage and capacity issues.
Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=755
Source: www.ashp.org
Sulfamethoxazole/Trimethoprim Injection
March 12, 2012
Products Affected - Description
Sulfamethoxazole 80 mg/trimethoprim 16 mg/mL injection, Teva
5 mL vial (NDC 00703-9503-03)
10 mL vial (NDC 00703-9514-03)
30 mL vial (NDC 00703-9526-01)
Reason for the Shortage
• Sulfamethoxazole/trimethoprim injection is on back order due to manufacturing problems and a
recall.
• Teva is the sole supplier of sulfamethoxazole/trimethoprim injection.
Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=613
Source: www.ashp.org
Sterile Empty Vials
March 12, 2012
Products Affected - Description
Sterile Empty Vials, Hospira
10 mL, 50 count (List #05816-11)
30 mL, 50 count (List #05816-31)
Empty Sterilized Vials, APP
5 mL, 25 count (NDC 63323-0001-05)
10 mL, 25 count (NDC 63323-0001-10)
30 mL, 25 count (NDC 63323-0001-30)
100 mL, 40 count (NDC 63323-0001-00)
Reason for the Shortage
• Hospira could not provide a reason for the shortage.
• APP reduced production of sterile empty vials to permit increased production of drug products
affected by critical shortages.
• Sterile empty vials may be available from medical supply distributors.
Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=890
Source: www.ashp.org
Indomethacin Injection
March 12, 2012
Products Affected - Description
41